Posts tagged “N.C. Biotech Center”

Updated January 25

Medicon - northern Europe's medical valley - meets RTP

Over the course of the two days, researchers shared their nanomedicine work on targeted drug delivery. Vaccine delivery. Drug toxicity. Scandinavians and North Carolinians shared the same language with the same terminology.

Medicon medtech companies Medicon medtech companies

January 13

NC Biotech Center loans Chapel Hill vaccine firm $250,000

Chapel Hil-based Heat Biologics is in the midst of a fundraising round expected to raise $4.1 million to finance clinical trials.

A graphic describes Heat's technology A graphic describes Heat's technology

January 4

Biotech Center awards $1 million in grants for university research

N.C. Biotech Center Scientists at NCSU, East Carolina and UNC-Wilmington receive $250,000 to fund work toward federal grant applications.

January 2

Drug startup NovaTarg targets hepatitis C

Ken Batchelor NovaTarg's research focuses on activating AMPK, an enzyme that regulates how cells use energy. The company says that its research with AMPK has applications in addressing liver diseases, diabetes and cancer.

December 29, 2011

Durham company gets $30K Biotech Center loan

NC Biotechnology Center NovaTarg, founded in Durham in 2009, is developing novel pharmaceutical products targeting liver diseases and diabetes.

Updated December 22, 2011

Opinion: New life sciences cluster report presents skewed view of RTP's activities

RTP The Triangle is outstanding for life sciences whether reports on U.S. markets score it first, last or in the middle.

Updated December 6, 2011

Beyond the numbers: The real strength of NC's life science cluster

Opinion: A new report shows we have plenty of work to do to keep North Carolina competitive in this volatile life-science environment. We need to open new doors to bring in more venture and other funding, for example. But during these difficult global economic times we are thankful that we keep adding life-science jobs statewide and companies keep calling us to help them relocate their businesses to North Carolina.

Biotech cluster study on Triangle Biotech cluster study on Triangle

November 21, 2011

More companies look to span farm, pharma worlds in NC

Biotech Biotechnology advances that boost crop yields and improve drought tolerance are well under way. But agbiotech research is also finding pharmaceutical applications, particularly for targeted drug delivery.

Updated November 18, 2011

Just call Charles Hamner the 'biofather' of biotech in NC

A recipient of a North Carolina Award for public service, the longtime head of the N.C. Biotechnology Center says he was "shocked" by the honor. "I was lucky enough to come along at the right time when the biotechnology industry was being developed here," he adds. The Award says otherwise.

Dr. Charles Hamner Dr. Charles Hamner

November 15, 2011

NC's 'biofather' sees more growth for biotech - and risks

Charles Hamner, who received a "North Carolina Award" for his efforts to establish and grow the biotechnology industry across North Carolina, sees "fantastic" potential for more growth. However, he's also concerned about capital, the training of future workers, and finding new leaders.

Charles Hamner sees lots to smile about in NC's future. Charles Hamner sees lots to smile about in NC's future.

October 31, 2011

Pets, people win in regenerative health partnership

Analysis: Animals may get a new lease on life and health, while also helping in the development of human therapies. It's the upshot of a regenerative medicine partnership announced by officials of North Carolina State University and Wake Forest Baptist Medical Center.

Growing organs in WFU lab Growing organs in WFU lab

October 31, 2011

IBM's 'Watson' supercomputer - Is it healthcare's future?

Dr. Watson? No. Just a tool. At NCSU biotech forum, an IBM exec says Watson can advance medical care and it will be controlled by the doctors.

Watson Watson

Updated October 26, 2011

NC Biotech Center names new board chairman

Architect and head of design firm John Atkins replaces venture capitalist Arthur Pappas.

John Atkins John Atkins

October 11, 2011

Big news at biotech event may not be a jobs announcement

Biotech & Life Science Gov. Bev Perdue could be announcing new life science jobs at the NCBIO annual meeting on Wednesday. But biotech executives are yearning for clarity in a muddled regulatory environment.

October 6, 2011

Japanese researchers unveil fat-derived stem cell uses

NU Tech logo In displays at its NU Tech Regenerative Medicine Roundtable, Nagoya University showed off several applications its researchers have discovered for stem cells derived from adipose tissue other than bone marrow.